Form D — Cerium Pharmaceuticals, Inc.
0001677995-26-000003 · filed Aug 6, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $2,544,000
- Total sold
- $750,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cerium Pharmaceuticals, Inc.
- CIK
- 1677995
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 312 MAIN STREET
GAITHERSBURG, MD 20878 - Phone
- 703-229-2508
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gregg A. Lapointe · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
Peter Collum · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Steve Eskenazi · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Robert Rubin · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Tom DePasquale · DirectorGaithersburg, MD Find on LinkedIn ↗
-
James Gale · DirectorGaithersburg, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗